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Abstract
Background: Calciphylaxis cutis is characterized by media calcification of arteries and, most
prominently, of cutaneous and subcutaneous arterioles occurring in renal insufficiency patients.
Case Report: A 53-year-old woman with chronic cardiac and renal failure complained of painful
crural, non-varicosis ulcers. She was hospitalized in an immobilized condition due to both the crural
ulcerations and the existing heart-failure state (NYHA III-IV) having pleural and pericardial
effusions, atrial fibrillation and weight loss of 30 kg over the past year. Despite normalization of
calcium-phosphorus balance and improvement of renal function, the clinical course of crural
ulcerations deteriorated during the following 3 months. After failure of surgical debridements,
multiple courses of sterile-maggot therapy were introduced at a late stage to stabilize the wounds.
The patient died of recurrent wound infections and sepsis paralleled by exacerbations of renal
malfunction.
Conclusions: The role of renal disease in vascular complications is discussed. Sterile-maggot
debridement may constitute a therapy for the ulcerated calciphylaxis at an earlier stage, i.e. when
first ulcerations appear.
Background
Calciphylaxis cutis is characterized by media calcification
of arteries and, most prominently, of cutaneous and sub-
cutaneous arterioles [1], as well as by intimal proliferation
and fibrosis [2]. The pathogenesis of Calciphylaxis
remains unclear as it differs from intima-based common
atherosclerosis and extravascular calcium-phosphate
deposits in organs such as the skin in Calcinosis cutis are
not involved. However, it appears to be associated with an
elevated serum calcium or phosphate concentration elic-
ited either by hyperparathyroidism or by vitamin-D
intake. Female gender appears to be a risk factor. Although
singular cases associated with non-renal diseases includ-
ing inflammatory bowel disease, cancer, and primary
hyperparathyroidism were reported [2], Calciphylaxis
cutis mainly occurs in end-stage renal insufficiency,
almost exclusively in patients undergoing kidney-replace-
ment therapy [2–4]. The prognosis in Calciphylaxis
patients is dramatically poor, with up to 6 months life
expectancy after appearance of ulcerations [3]. Emphasiz-
ing its difference from intima-based atherosclerosis, it is
also called calcific uremic arteriolopathy [1].
Case Report
A 53-year-old woman with a body mass index of 27.5 kg/
m2 having chronic renal failure and chronic heart failure
complained of painful crural, non-varicosis ulcers that
started 8 months previously as livid palpable plaques or
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nodules within and underneath the skin, transforming
into ulcers five weeks before admission and showing little
sign of healing since. While a single, 2.5-cm ulcer closed,
other ulcerations appeared at the right calf (Figure 1).
Hence, the patient was admitted to a dermatologic depart-
ment in an immobilized, weak condition having heart
failure due to hypertensive and ischemic heart disease
(left ventricular ejection fraction: 30 %, NYHA III-IV). Fur-
thermore, she had a loss of appetite and lost 30 kg during
the past year. Hypertension, recurrent ascendant urinary-
tract infections and renal atherosclerosis were likely
causes of renal failure. In addition, the patient had regu-
larly taken analgesics. Systemic atherosclerosis was indi-
cated by history of a myocardial infarction 5 years
previously and by limitations of walking distance. In a
coronary angiogram, a single-vessel coronary-artery dis-
ease was diagnosed necessitating an elective percutaneous
coronary recanalization and stent deployment as well as
three more percutaneous coronary interventions for
repeated late in-stent restenosis during the previous 5
years. Clinical signs of the heart-failure state included
both pleural and pericardial effusions, secondary mitral
regurgitation due to cardiac dilation, and atrial fibrilla-
tion. The prevalent pericardial effusion was not deemed
significant for cardiac filling as determined by echocardi-
ography. Six months before admission, an Implantable
Converter/Defibrillator (ICD) was inserted because of
pre-syncope, non-sustained ventricular tachycardias in
the Holter-ECG and a positive electrophysiological test
result.
Laboratory tests revealed a normal plasma concentration
of parathyroid hormone (5.02 pmol/l, normal: 1.1–6.9),
Vitamin (1,25-OH)-D3 deficiency (7.1 pg/ml, normal:
20.2–46.2), however, slightly elevated calcium (2.66
mmol/l, normal: 2.02–2.6) concentration. Potassium
(4.3 mmol/l) and phosphate (1.26 mmol/l) concentra-
tions were normal. Glomerular filtration rate estimated by
MDRD equation [5] was 25.4 ml/min (creatinine: 207
µmol/l; urea: 30.2 mmol/l; albumin: 35.1 g/l) at admis-
sion indicative for renal failure. Further, low HDL choles-
terol (0.86 mmol/l, normal: >0.9), high triglycerides
(3.06 mmol/l, normal: <2.3), yet a normal LDL choles-
terol (3.49 mmol/l, normal: <4.2) in absence of statins to
which the patient claimed to be allergic, were found. Leu-
kocyte count and C-reactive protein were found to be ele-
vated at least during the 12 months prior to admission,
ranging from 10–15 Gpt/l (normal:4–9) and 60–200 mg/
l (normal: <5), respectively. Ferritin was in the normal
range between 200 and 300 ng/ml (normal: 13–300), nei-
ther supporting an infection as an acute-phase reactant
nor being the reason for the prevalent normocytic, nor-
mochromic anemia (hemoglobin 6 mmol/l, hematocrit
31%). However, an iron deficiency could have limited fur-
ther rises of ferritin due to infection. The anemia was not
due to erythropoietin deficiency as reticulocytes were 15
Gpt/l. Urine tests showed a microproteinuria (0.25 g/l)
and leukocyturia (25/µl). After cessation of coumadin
therapy for atrial fibrillation, the International Normal-
ized Ratio leveled off at 1.42 (normal: 1) in presence of
low-dose heparine. Liver enzymes including serum alca-
line phosphatasis were between 16 and 19 µmol/l*s (nor-
mal: <4.2) and gamma-glutamyl transferase between 9
and 14 µmol/l*s (normal: <0.6), while transaminases
were within normal range. Ultrasound examination
revealed small kidneys (9 cm longitudinally) with loss of
clarity of architecture and multiple cysts. The renal cortex
was narrowed to 7 mm, ureters were not dilated. A whole-
body bone scintigraphy was negative for bone metastases
or osteomyelitis. Ultrasonographic examinations of the
thyroid gland were unrevealing; parathyroid bodies were
not identified. The radiologic search for nonvascular soft-
tissue calcifications was negative. Systemic lupus ery-
thematosus or other types of autoimmune diseases were
ruled out by negative antibody screening tests. The diag-
nosis Calciphylaxis cutis was established by cutaneous
biopsy.
Hypercalcaemia was readily normalized by diuretic ther-
apy with torasemide in combination with standard heart-
failure therapy including aldosterone antagonist, ACE
inhibitor, beta-adrenergic blockade and digitalis over a
one-month period. Possible reasons for the
hypercalcaemia like hyperparathyroidism or high vitamin
D serum levels were ruled out, parathyroid hormon-
related peptide was not determined. Glomerular filtration
rate improved to 33.1 ml/min under balanced fluid-sub-
stitution. Thus, renal function in this patient was mid-
Calciphylaxis cutis on admission Figure 1
Calciphylaxis cutis on admission. After transfer to the 
dermatologic department, about 1 month after first incidence 
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stage impaired with potential to recover under therapy.
However, fluid overload had to be avoided because of the
heart-failure condition. Once electrolytes, including
plasma potassium fell, an incessant ventricular tachycar-
dia triggered the ICD. Therefore, potassium was given to
obtain a high-normal plasma concentration, and an ami-
odarone therapy was started.
Despite wound care on a daily basis both in hospital and
in ambulatory care, the cutaneous ulcers worsened. 2
months after first admission, the patient was readmitted
because of exacerbated ulcers on both lower legs (Figure
2). Hydrocolloid dressings failed because of the size and
number of wounds. Instead, an active-charcoal absorband
dressing combined with repeated surgical necrectomy was
applied to stabilize the wound situation in conjunction
with antibiotic therapy guided by wound-secretion-
derived microbiological cultures. Parathyroid function
remained normal. Following a 1-month consolidation
therapy the patient was discharged with a stable wound
condition to continue wound care at home. However, the
large extent of those ulcers affecting both lower legs
remained unchanged at the time of discharge compared to
admission.
About 4 months after first admission, the patient was
readmitted with signs of sepsis necessitating an escalated
antibiotic treatment and surgical wound care. Yet conven-
tional necrectomy proved ineffective. Therefore, maggot
debridement therapy using sterile maggots of the green-
bottle fly Lucilia sericata was introduced. Following four
courses, the wounds gradually improved, granulated and
showed signs of healing, yet the large extent of those
wounds remained, rendering the patient at high risk of
reinfection (Figure 3). As an adjunct antibiotic therapy, a
combination of piperacillin-combactam was given over 9
days. The subcutaneous nodule-like tumors continued to
occur at new locations. The patient's overall condition
remained poor. Six days after being transferred to a pri-
mary hospital, she was readmitted because of acute renal
failure. In addition, she suffered from the consequences of
a stroke, with right-side hemiparesis, as well as from wors-
ened crural ulcerations and a new pre-sacral pressure-sore
lesion. A urinary-tract infection with Pseudomonas aerugi-
nosa was diagnosed. The patient died within 4 days of a
systemic-inflammatory response syndrome primarily due
to her superinfected, poorly controllable wounds.
The diagnosis of Calciphylaxis cutis was confirmed by
autopsy, revealing small- and medium-sized blood-vessel
calcifications within the ulcerated skin of the lower legs as
previously seen in the biopsy (Figure 4 and 5). Even cap-
illaries were found to be surrounded by calcific deposits.
The patient was shown to have severe calcified
atherosclerotic lesions occasionally involving the whole
circumference of the aorta and the coronary arteries with
an in-stent restenosis within the right coronary artery. Fur-
thermore, the patient presented intermediate-grade
atherosclerosis in renal as well as in lower-leg peripheral
arteries. Unusual locations of calcifications were the wall
of the left atrium of the heart (Figure 6) and pulmonary
arteries.
Discussion
Here we report a case of ulcerated Calciphylaxis cutis in
the presence of a moderate renal insufficiency in contrast
Calciphylaxis cutis, 2 months after admission Figure 2
Calciphylaxis cutis, 2 months after admission. Large 
ulcerations at both lower legs with signs of superinfection.
Calciphylaxis cutis, 4 months after admission Figure 3
Calciphylaxis cutis, 4 months after admission. Size 
enlargement of calciphylactic ulcerations. Maggot debride-
ment therapy abolished superinfection to a large extent.BMC Nephrology 2003, 4 http://www.biomedcentral.com/1471-2369/4/8
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to most previous observations that suggest Calciphylaxis
cutis to be associated with terminal renal insufficiency
[3,4]. Moreover, the actual plasma levels of calcium and
phosphorus seemed to play a minor role than assumed
from previous evidence [3]. However, in spite of measures
to preserve renal function, the clinical course of Calciphy-
laxis cutis was rapidly progressive and virtually undeterred
by treatment in our patient. The skin ulcerations due to
Calciphylaxis cutis constantly deteriorated over less than
6 months from first admission. Alternative therapeutic
options including glucocorticoids were not deemed salu-
tary in the presence of ulcerations [3]. Sterile maggot deb-
ridement therapy was more successful than surgical
debridement in this patient. However, it was introduced
late. In line with previous evidence [6], we strongly
encourage its use in ulcerated Calciphylaxis cutis in
combination with a broad-spectrum, Pseudomonas – effec-
tive antibiotic earlier on to avoid superinfections and to
facilitate the granulation process. Overall, screening of
renal-disease patients for Calciphylaxis cutis in the non-
ulcerated stage seems to be crucial to timely address risk
factors associated with the disease. Classic and putative
risk factors for Calciphylaxis cutis derived from this case
are summarized below.
Cardiovascular risk factors were low HDL cholesterol and
high triglycerides, history of cigarette smoking during the
previous 10 years (20-pack years) and arterial hyperten-
sion. The prevalent renal disease appears to be both a car-
diovascular risk factor [7] and risk factor for Calciphylaxis
[3]. Further, the patient may have had a genetic disposi-
tion to cardiovascular disease, as her mother died of myo-
cardial infarction prematurely. Lipoprotein (a) and
homocysteine levels were not determined. C-reactive pro-
tein elevation is likely due to the skin ulcers. However, it
was high during the 12 months prior to death and was
probably high even before that as her history of urinary-
tract infections revealed, thus, making it eligible as a con-
tributing factor for atherosclerosis [8]. A slight distur-
Calcifications of skin arteries, arterioles and capillaries Figure 4
Calcifications of skin arteries, arterioles andt capillar-
ies. Biopsy and autopsy revealed calcifications of small arter-
ies, arterioles and capillaries within the ulcerated skin.
Calcifications of skin arteries, arterioles and capillaries Figure 5
Calcifications of skin arteries, arterioles and capillar-
ies. Biopsy and autopsy revealed calcifications of small arter-
ies, arterioles and capillaries within the ulcerated skin.
Calcifications of the left atrial wall of the heart Figure 6
Calcifications of the left atrial wall of the heart. 
Autopsy revealed calcifications and endocardial fibrosis 
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bance of calcium-phosphorus metabolism as well as a
history of obesity, former coumadin use, and a possible
underlying vitamin-K deficiency based on a steadily ele-
vated international normalized ratio after coumadin dis-
continuation are prevalent, putative risk factors for
Calciphylaxis [2]. Yet, the mechanism of these dissemi-
nated calcifications in small cutaneous arteries, and capil-
laries as well as in conductive arteries, pulmonary arteries
and the left atrium is by far not explained. Future research
will clarify whether matrix-protein dysfunction elicited by
Vitamin-K deficient state is in play [9,10] which may affect
both pyrophosphate and calcium metabolism [1,11] as
well as wound healing [3].
Taken together, Calciphylaxis cutis is thought to arise
from the arterial media layer rendering it different from
intimal calcifications seen in common atherosclerosis and
from extravascular organ calcifications such as Calcinosis
cutis. The in-stent restenosis problem in our patient may
reflect a propensity of intimal proliferation and fibrosis
usually seen in Calciphylaxis [2]. Here, we speculate that
the patient actually had both Calciphylaxis cutis repre-
sented by calcifications of small arteries, arterioles and
capillaries of the skin as well as systemic atherosclerosis as
primarily seen in conductive arteries.
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